Raises $80M at $10 per share; becomes first new industrial biotech company to complete IPO in more than a year. What went right and how? Is the IPO window re-opening? In Minnesota, BioAmber announced the pricing of its initial public offering of 8 million units consisting of one share of common stock and one warrant […]
In Texas, KiOR announced a Q1 2013 net loss of $31.3 million, or $0.30 per share, compared to a Q1 2012 loss of $16.8 million. The company reported revenues of $71,000. “Building on the first gallons of cellulosic diesel we shipped in March, we continue to make progress with operations at our Columbus facility,” said […]
If you have been following events in California, oil refiners have been waging a well-funded war on California’s Low Carbon Fuel Standard, which requires oil companies to reduce the carbon pollution from gasoline and diesel by 10 percent by 2020. Centerpiece in their strategy was a June 2012 report from Boston Consulting Group (funded by […]
The sector’s perennial hottest company strikes again — with “potentially disruptive” new technology to change the positioning and performance of triglyceride oils. In California, Solazyme and AkzoNobel announced an agreement targeting the development of advanced tailored triglyceride oils and commercial sales for near-term product supply. The agreement focuses on supply for the chemical giant’s Surface […]
In California, Garden State bioEnterprises announced that it has adopted OriginOil’s harvesting technology as a key component of its proprietary production system for the high-value product Astaxanthin. In a recent trial, GS bioE concentrated its algae with an OriginOil Algae Appliance and then successfully stressed the cells into Astaxanthin-bearing product. ”Being able to concentrate the […]
Will BioAmber complete its IPO? As the industry waits, fingers crossed, the biosuccinic developer sweetens the pot with warrants, lower share prices. In Canada, BioAmber has reduced the proposed price range for its IPO to $10-$12 per share, down from a $15-$17 range — as it seeks to keep the initial public offering on track. […]
In California, Intrexon Corporation, a next generation synthetic biology company, announced that it has closed a Series F preferred investment round of $150 million, bringing the company’s total capital raised to $509 million. Undisclosed investors accounted for the majority of the round, with current investors, including affiliates of Randal J. Kirk, Intrexon’s Chairman and CEO, […]
Is there bio-based relief for the harried taxpayer in sight? Could conservationists, growers and biofuels producers find common ground in adapting the Conservation Reserve Program for bioenergy? Could the US save $270M/year, and strengthen two carbon-reducing laws on the books? The eminent Iowa State economist Bruce Babcock recently opined: “The future of cellulosic biofuels in […]
EcoManLeader #Renewable Biofuels scientists are asking more complex questions about how molecules spin, bond, and break when… EuroGeosciences: Sylvian LeDuc on why woody biofuels wouldn’t be the best plan for the EU: opean: Renewable Energy Association fires back at green groups pushing for subsidy cuts:
Who’s behind the 8-ball, the algae optimists or pessimists? It all comes down to the pace of innovation in 8 cores. Predictions of when algae biofuels will become an everyday option at scale are, famously, all over the map — ranging from “the next few years” to “never”. In a recent survey of its members, […]
